Regulus Therapeutics Inc
RGLS
Company Profile
Business description
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
Contact
4224 Campus Point Court
Suite 210
San Diego CA 92121
USAT: +1 858 202-6300
E: information@regulusrx.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
28
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,205.50 | 3.10 | -0.04% |
CAC 40 | 7,513.73 | 84.90 | -1.12% |
DAX 40 | 18,387.46 | 170.24 | -0.92% |
Dow JONES (US) | 39,853.87 | 504.22 | -1.25% |
FTSE 100 | 8,153.69 | 13.68 | -0.17% |
HKSE | 17,311.05 | 158.31 | -0.91% |
NASDAQ | 17,342.41 | 654.94 | -3.64% |
Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
NZX 50 Index | 12,472.05 | 58.94 | -0.47% |
S&P 500 | 5,427.13 | 128.61 | -2.31% |
S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
Worley Ltd WOR | 15.23 | 0.04 | 0.26% |
Mesoblast Ltd MSB | 1.26 | 0.05 | -3.83% |
Telstra Group Ltd TLS | 3.90 | 0.02 | 0.52% |